Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-10-16 Option Award |
2023-10-17 6:37 pm |
N/A 2033-10-15 |
Turnstone Biologics Corp. | TSBX | Burgess Michael F. Interim Chief Medical Officer |
11,464 | $0 | 11,464 (Direct) |
View |
Ownership |
2023-07-20 9:48 pm |
N/A 2027-09-14 |
Turnstone Biologics Corp. | TSBX | Burgess Michael F. Interim Chief Medical Officer |
0 | $0 | 210,422 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 2:21 pm |
N/A 2033-06-22 |
SYNLOGIC INC. | SYBX | Burgess Michael F. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-07-18 Tax Withholding |
2022-07-20 6:02 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development |
3,103 | $28.47 | 49,584 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:29 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development |
12,185 | $0 | 52,687 (Direct) |
View |
| 2022-06-01 Tax Withholding |
2022-07-05 5:29 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development |
2,672 | $19.61 | 52,687 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:15 pm |
N/A 2032-06-09 |
SYNLOGIC INC. | SYBX | Burgess Michael F. Director |
27,000 | $0 | 27,000 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:23 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development |
64,526 | $0 | 92,026 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:12 pm |
N/A 2031-06-10 |
SYNLOGIC INC. | SYBX | Burgess Michael F. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-01 5:25 pm |
N/A 2031-06-01 |
SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development |
252,500 | $0 | 252,500 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 5:31 pm |
N/A 2030-06-04 |
SYNLOGIC INC. | SYBX | Burgess Michael F. Director |
15,000 | $0 | 15,000 (Direct) |
View |